05:42 EDT Sanofi (SNY) to acquire Blueprint Medicines (BPMC) for $129 per share in cash
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BPMC:
- M&A News: Sanofi Expands Cancer Drug Portfolio with $9.1B Blueprint Medicines Acquisition
- ‘Stay Invested’: Wells Fargo Suggests 2 Stocks to Ride the Market Recovery
- Blueprint Medicines’ Ayvakit Poised to Maintain Market Leadership Amidst Competitive Challenges
- Cautious Optimism: Blueprint Medicines’ Hold Rating Amid Mixed Growth Signals
- Blueprint Medicines: Strong Market Position and Growth Potential Justify Buy Rating with $135 Price Target